105 related articles for article (PubMed ID: 23205728)
1. Improved oxidative stress and cardio-metabolic status in obese prepubertal children with liver steatosis treated with lifestyle combined with Vitamin E.
D'Adamo E; Marcovecchio ML; Giannini C; de Giorgis T; Chiavaroli V; Chiarelli F; Mohn A
Free Radic Res; 2013 Mar; 47(3):146-53. PubMed ID: 23205728
[TBL] [Abstract][Full Text] [Related]
2. [Non-alcoholic fatty liver disease and its association with clinical and biochemical variables in obese children and adolescents: effect of a one-year intervention on lifestyle].
Santomauro M; Paoli-Valeri M; Fernández M; Camacho N; Molina Z; Cicchetti R; Valeri L; Dávila de Campagnaro E; Arata-Bellabarba G
Endocrinol Nutr; 2012; 59(6):346-53. PubMed ID: 22717644
[TBL] [Abstract][Full Text] [Related]
3. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial.
Nobili V; Manco M; Devito R; Di Ciommo V; Comparcola D; Sartorelli MR; Piemonte F; Marcellini M; Angulo P
Hepatology; 2008 Jul; 48(1):119-28. PubMed ID: 18537181
[TBL] [Abstract][Full Text] [Related]
4. Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study.
Reinehr T; Schmidt C; Toschke AM; Andler W
Arch Dis Child; 2009 Jun; 94(6):437-42. PubMed ID: 19224892
[TBL] [Abstract][Full Text] [Related]
5. Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease.
Pacifico L; Arca M; Anania C; Cantisani V; Di Martino M; Chiesa C
Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):1010-6. PubMed ID: 23018041
[TBL] [Abstract][Full Text] [Related]
6. Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children.
Wang CL; Liang L; Fu JF; Zou CC; Hong F; Xue JZ; Lu JR; Wu XM
World J Gastroenterol; 2008 Mar; 14(10):1598-602. PubMed ID: 18330955
[TBL] [Abstract][Full Text] [Related]
7. Thyroid dysfunction in obese pre-pubertal children: oxidative stress as a potential pathogenetic mechanism.
D'Adamo E; De Leonibus C; Giannini C; Corazzini V; De Remigis A; Chiarelli F; Mohn A
Free Radic Res; 2012 Mar; 46(3):303-9. PubMed ID: 22239613
[TBL] [Abstract][Full Text] [Related]
8. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
[TBL] [Abstract][Full Text] [Related]
9. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice.
Nobili V; Marcellini M; Devito R; Ciampalini P; Piemonte F; Comparcola D; Sartorelli MR; Angulo P
Hepatology; 2006 Aug; 44(2):458-65. PubMed ID: 16871574
[TBL] [Abstract][Full Text] [Related]
10. Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease.
Nobili V; Manco M; Devito R; Ciampalini P; Piemonte F; Marcellini M
Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1553-61. PubMed ID: 17206944
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis.
Reinehr T; Woelfle J; Wunsch R; Roth CL
J Clin Endocrinol Metab; 2012 Jun; 97(6):2143-50. PubMed ID: 22438225
[TBL] [Abstract][Full Text] [Related]
12. Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients.
Verrijken A; Francque S; Mertens I; Talloen M; Peiffer F; Van Gaal L
Int J Obes (Lond); 2010 May; 34(5):899-907. PubMed ID: 20142825
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of metformin and vitamin E versus prescriptive diet in obese adolescents with fatty liver.
Akcam M; Boyaci A; Pirgon O; Kaya S; Uysal S; Dundar BN
Int J Vitam Nutr Res; 2011 Nov; 81(6):398-406. PubMed ID: 22673924
[TBL] [Abstract][Full Text] [Related]
14. Investigation of anthropometric, biochemical and dietary parameters of obese children with and without non-alcoholic fatty liver disease.
Papandreou D; Karabouta Z; Pantoleon A; Rousso I
Appetite; 2012 Dec; 59(3):939-44. PubMed ID: 23000278
[TBL] [Abstract][Full Text] [Related]
15. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J
Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
[TBL] [Abstract][Full Text] [Related]
16. [Fatty liver disease, insulin resistance and adiponectin in an obese pediatric population].
López-Capapé M; López-Bermejo A; Alonso Blanco M; Lara Orejas E; Corbatón Blasco J; Barrio Castellanos R
An Pediatr (Barc); 2009 Dec; 71(6):495-501. PubMed ID: 19850541
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic steatohepatitis in children.
Nanda K
Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
[TBL] [Abstract][Full Text] [Related]
18. Changes of cardiovascular risk factors in obese children effects of inpatient and outpatient interventions.
Reinehr T; de Sousa G; Wabitsch M
J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):506-11. PubMed ID: 17033527
[TBL] [Abstract][Full Text] [Related]
19. Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study.
Yakaryilmaz F; Guliter S; Savas B; Erdem O; Ersoy R; Erden E; Akyol G; Bozkaya H; Ozenirler S
Intern Med J; 2007 Apr; 37(4):229-35. PubMed ID: 17388862
[TBL] [Abstract][Full Text] [Related]
20. Plasma advanced glycation end products are decreased in obese children compared with lean controls.
Sebeková K; Somoza V; Jarcusková M; Heidland A; Podracká L
Int J Pediatr Obes; 2009; 4(2):112-8. PubMed ID: 18645732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
